Comprehensive prognostic model for immunotherapy in small cell lung cancer: a multi-center study integrating clinical and blood biomarkers
This study developed a convenient and effective multi-factor survival prediction model based on clinical and hematological markers. The model provides a tool for personalized management of immunotherapy in SCLC patients. It offers new insights and practical evidence for precision treatment in SCLC.
Authors
- Lin Tan (ORCID: https://orcid.org/0000-0002-9400-1754)
- Yun Ding (ORCID: https://orcid.org/0000-0002-7012-5621)
- Yuhang Jiang (ORCID: https://orcid.org/0000-0001-5048-7601)
- Yanling Jing
- Xin Li (ORCID: https://orcid.org/0000-0003-2525-9679)
- Han Zhang (ORCID: https://orcid.org/0000-0001-7355-925X)
- Jie Zhang (ORCID: https://orcid.org/0000-0002-0249-6674)
- Daqiang Sun (ORCID: https://orcid.org/0009-0001-6315-0001)
- Jingxian Wang (ORCID: https://orcid.org/0000-0002-9484-6570)
- Qiuqiao Mu
Institutions
- Qingdao University (CN)
- Yuhuangding Hospital (CN)
- Qingdao Municipal Hospital (CN)
- Fujian Provincial Hospital (CN)
- Tianjin Chest Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-10
- DOI
- https://doi.org/10.3389/fonc.2025.1680624
- Citations
- 2
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Tianjin Science and Technology Program